Fetal Circulation and Patent Ductus Arteriosus
Posted by Surgery on Sep 4, 2008
Persistent patency of the ductus arteriosus is a common problem in sick, premature infants and can lead to high-output cardiac failure due to aortic to pulmonary artery shunting. In the fetus, 69% of combined ventricular output is oxygenated blood that travels from the placenta to the fetal right atrium through the umbilical vein, ductus venosus, and inferior vena cava (Fig. 4-1:Calan). A portion of oxygen-rich blood that enters the right atrium from the inferior vena cava is shunted preferentially across the atrial septum through the foramen ovale to the left atrium. This oxygenated blood is pumped into the ascending aorta by the left ventricle and is thus more available to the coronary arteries and subclavian and carotid arteries than to the systemic circulation. Because only about 7% of fetal right ventricular output goes to the lungs, owing to supersystemic pulmonary vascular resistance during fetal life, the right ventricle performs about twice as much work as the left ventricle during fetal life. About 90% of right ventricular output flows to the systemic circulation through the ductus arteriosus. Fetal oxygen tension is usually 25 to 30 mm Hg.The ductus arteriosus shunts blood flow from the pulmonary artery into the aorta. Within hours to days after delivery in full-term infants, as pulmonary vascular resistance falls and arterial oxygenation increases, the patent ductus arteriosus (PDA:Calan) closes by constriction of vascular smooth muscle in its wall, which shortens and narrows its lumen (9:Calan). Failure of the PDA to close after postnatal reduction in pulmonary vascular resistance results in left-to-right shunting from aorta to pulmonary artery, pulmonary hyperperfusion, high-output congestive heart failure, and a diastolic steal syndrome, which reduces perfusion to the splanchnic and renal vascular beds. Failure of closure with persistently supersystemic postnatal pulmonary vascular resistance results in right-to-left shunting from pulmonary artery to aorta and systemic hypoxia proportional to the magnitude of the pulmonic-aortic pressure gradient.
In the preterm infant, functional closure is often delayed. Clinical evidence of a hemodynamically significant PDA includes a systolic or continuous murmur, bounding pulses with widened pulse pressure, hyperdynamic precordium, tachypnea, tachycardia, hepatomegaly, and worsening respiratory failure. Confirmation of patency can be made by echocardiography.
Management of these infants must be individualized. For a premature infant with a hemodynamically significant PDA, pharmacologic interruption with indomethacin should be considered. Symptoms of PDA respond to treatment with indomethacin in about 70% of infants (10:Calan). Symptoms recur in about 30% of these infants, owing to reopening of the ductus arteriosus. These infants require additional treatment with indomethacin or surgical ligation. Because of side effects of indomethacin therapy, which include inhibition of platelet function, reduction of splanchnic blood flow, bowel perforation, and reduction of renal blood flow, treatment of infants with asymptomatic PDA remains controversial (11:Calan).
Surgical interruption of the ductus arteriosus is a safe alternative to indomethacin treatment in infants unresponsive to indomethacin or in those whose clinical situation contraindicates its use (12,13:Calan). The operative mortality rate at centers where experienced surgical teams are available is less than 1%. The morbidity of the procedure is also low (12,13). Nonsurgical transcatheter closure has also been used with increasing success (13).



Greetings, I the practising surgeon from Serbia. Call me Ivan Govak. In the works I use works
by an unknown author, if it let me know, and also works of others practics doctors. I have a family and two charming children.